Copyright Reports & Markets. All rights reserved.

Global Stem Cells Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Stem Cells Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Allogeneic
      • 1.4.3 Autologous
    • 1.5 Market by Application
      • 1.5.1 Global Stem Cells Market Share by Application (2014-2025)
      • 1.5.2 Musculoskeletal Disorder
      • 1.5.3 Wounds & Injuries
      • 1.5.4 Cornea
      • 1.5.5 Cardiovascular Diseases
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Stem Cells Market Size
    • 2.2 Stem Cells Growth Trends by Regions
      • 2.2.1 Stem Cells Market Size by Regions (2014-2025)
      • 2.2.2 Stem Cells Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Stem Cells Market Size by Manufacturers
      • 3.1.1 Global Stem Cells Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Stem Cells Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
    • 3.2 Stem Cells Key Players Head office and Area Served
    • 3.3 Key Players Stem Cells Product/Solution/Service
    • 3.4 Date of Enter into Stem Cells Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Stem Cells Market Size by Type (2014-2019)
    • 4.2 Global Stem Cells Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Stem Cells Market Size (2014-2019)
    • 5.2 Stem Cells Key Players in United States
    • 5.3 United States Stem Cells Market Size by Type
    • 5.4 United States Stem Cells Market Size by Application

    6 Europe

    • 6.1 Europe Stem Cells Market Size (2014-2019)
    • 6.2 Stem Cells Key Players in Europe
    • 6.3 Europe Stem Cells Market Size by Type
    • 6.4 Europe Stem Cells Market Size by Application

    7 China

    • 7.1 China Stem Cells Market Size (2014-2019)
    • 7.2 Stem Cells Key Players in China
    • 7.3 China Stem Cells Market Size by Type
    • 7.4 China Stem Cells Market Size by Application

    8 Japan

    • 8.1 Japan Stem Cells Market Size (2014-2019)
    • 8.2 Stem Cells Key Players in Japan
    • 8.3 Japan Stem Cells Market Size by Type
    • 8.4 Japan Stem Cells Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Stem Cells Market Size (2014-2019)
    • 9.2 Stem Cells Key Players in Southeast Asia
    • 9.3 Southeast Asia Stem Cells Market Size by Type
    • 9.4 Southeast Asia Stem Cells Market Size by Application

    10 India

    • 10.1 India Stem Cells Market Size (2014-2019)
    • 10.2 Stem Cells Key Players in India
    • 10.3 India Stem Cells Market Size by Type
    • 10.4 India Stem Cells Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Stem Cells Market Size (2014-2019)
    • 11.2 Stem Cells Key Players in Central & South America
    • 11.3 Central & South America Stem Cells Market Size by Type
    • 11.4 Central & South America Stem Cells Market Size by Application

    12 International Players Profiles

    • 12.1 Osiris Therapeutics
      • 12.1.1 Osiris Therapeutics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Stem Cells Introduction
      • 12.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2014-2019)
      • 12.1.5 Osiris Therapeutics Recent Development
    • 12.2 NuVasive
      • 12.2.1 NuVasive Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Stem Cells Introduction
      • 12.2.4 NuVasive Revenue in Stem Cells Business (2014-2019)
      • 12.2.5 NuVasive Recent Development
    • 12.3 Chiesi Pharmaceuticals
      • 12.3.1 Chiesi Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Stem Cells Introduction
      • 12.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2014-2019)
      • 12.3.5 Chiesi Pharmaceuticals Recent Development
    • 12.4 JCR Pharmaceutical
      • 12.4.1 JCR Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Stem Cells Introduction
      • 12.4.4 JCR Pharmaceutical Revenue in Stem Cells Business (2014-2019)
      • 12.4.5 JCR Pharmaceutical Recent Development
    • 12.5 Pharmicell
      • 12.5.1 Pharmicell Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Stem Cells Introduction
      • 12.5.4 Pharmicell Revenue in Stem Cells Business (2014-2019)
      • 12.5.5 Pharmicell Recent Development
    • 12.6 Medi-post
      • 12.6.1 Medi-post Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Stem Cells Introduction
      • 12.6.4 Medi-post Revenue in Stem Cells Business (2014-2019)
      • 12.6.5 Medi-post Recent Development
    • 12.7 Anterogen
      • 12.7.1 Anterogen Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Stem Cells Introduction
      • 12.7.4 Anterogen Revenue in Stem Cells Business (2014-2019)
      • 12.7.5 Anterogen Recent Development
    • 12.8 MolMed
      • 12.8.1 MolMed Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Stem Cells Introduction
      • 12.8.4 MolMed Revenue in Stem Cells Business (2014-2019)
      • 12.8.5 MolMed Recent Development
    • 12.9 Takeda (TiGenix)
      • 12.9.1 Takeda (TiGenix) Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Stem Cells Introduction
      • 12.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2014-2019)
      • 12.9.5 Takeda (TiGenix) Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells). Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc.). This report studies the Stem Cell Therapy. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
      In 2018, the global Stem Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cells development in United States, Europe and China.

      The key players covered in this study
      Osiris Therapeutics
      NuVasive
      Chiesi Pharmaceuticals
      JCR Pharmaceutical
      Pharmicell
      Medi-post
      Anterogen
      MolMed
      Takeda (TiGenix)

      Market segment by Type, the product can be split into
      Allogeneic
      Autologous

      Market segment by Application, split into
      Musculoskeletal Disorder
      Wounds & Injuries
      Cornea
      Cardiovascular Diseases
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Stem Cells status, future forecast, growth opportunity, key market and key players.
      To present the Stem Cells development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Stem Cells are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now